RARA CRAFT DATABASE for FDA Medical Devices
510(k)K162095

FDA DEVICE FACTS

Non-Sterile, Powder Free Nitrile Examination Gloves, Tested for use with Chemotherapy Drugs (Original Blue, Cobalt Blue)

Yty Industry (Manjung) Sdn Bhd

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATENovember 2, 2016PRODUCT CODELZA

Indications for use

A patient examination gloves is a disposable device intended for medical purpose that is worn on the examiner’s hand or finger to prevent contamination between patient and examiner. This glove is also tested for use against Chemotherapy Drugs. The Chemotherapy Drugs and its permeation time is listed as below. Tested Chemotherapy Drug And Concentration Average Breakthrough Detection Time Carboplatin, 10 mg/ml > 240 minutes Carmustine (3.3 mg/ml) 1.84 minutes Cisplatin (BCNU), 1.0 mg/ml > 240 minutes Cyclophosphamide (Cytoxan), 20.0 mg/ml > 240 minutes Dacarbazine (DTIC), 10.0 mg/ml > 240 minutes Doxorubicin Hydrochloride, 2.0 mg/ml > 240 minutes Etoposide (Toposar), 20.0 mg/ml > 240 minutes Fluorouracil, 50.0 mg/ml > 240 minutes Ifosfamide , 50.0 mg/ml > 240 minutes Methotrexate, 25 mg/ml > 240 minutes Mitomycin C, 0.5 mg/ml > 240 minutes Mitoxantrone, 2 mg/ml > 240 minutes Paclitaxel (Taxol), 6.0 mg/ml > 240 minutes ThioTEPA (10.0 mg/ml) 0.76 minutes Vincristine Sulfate, 1.0 mg/ml > 240 minutes The following chemotherapy drugs and concentration have extremely low permeation time. Carmustine (3.3 mg/ml): 1.84 minutes ThioTEPA (10.0 mg/ml): 0.76 minutes A patient examination gloves is a disposable device intended for medical purpose that is worn on the examiner’s hand or finger to prevent contamination between patient and examiner. This glove is also tested for use against Chemotherapy Drugs. The Chemotherapy Drugs and its permeation time is listed as below. Tested Chemotherapy Drug And Concentration Average Breakthrough Detection Time Carboplatin, 10 mg/ml > 240 minutes Carmustine (3.3 mg/ml) 1.82 minutes Cisplatin (BCNU), 1.0 mg/ml > 240 minutes Cyclophosphamide (Cytoxan), 20.0 mg/ml > 240 minutes Dacarbazine (DTIC), 10.0 mg/ml > 240 minutes Doxorubicin Hydrochloride, 2.0 mg/ml > 240 minutes Etoposide (Toposar), 20.0 mg/ml > 240 minutes Fluorouracil, 50.0 mg/ml > 240 minutes Ifosfamide , 50.0 mg/ml > 240 minutes Methotrexate, 25 mg/ml > 240 minutes Mitomycin C, 0.5 mg/ml > 240 minutes Mitoxantrone, 2 mg/ml > 240 minutes Paclitaxel (Taxol), 6.0 mg/ml > 240 minutes ThioTEPA (10.0 mg/ml) 0.93 minutes Vincristine Sulfate, 1.0 mg/ml > 240 minutes The following chemotherapy drugs and concentration have extremely low permeation time. Carmustine (3.3 mg/ml): 1.82 minutes ThioTEPA (10.0 mg/ml): 0.93 minutes

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 2, 2026